Trial Details
RECRUITINGBasic Information
| Clinical ID | c570 |
|---|---|
| Identifier | NCT06408935 |
| Trial Title | Transmural Healing and Disease-Modifying Effect of Guselkumab in Crohn's Disease Patients |
| Trial URL | Visit Original Page |
Study Information
| Study Results | NO |
|---|---|
| Conditions | Crohn's Disease |
| Interventions | DRUG: Guselkumab |
Participant Information
| Sponsor | Janssen-Cilag Ltd. |
|---|---|
| City | San Francisco |
| Country/Region | United States |
Enrollment Criteria
| Sex Requirement | ALL |
|---|---|
| Age Requirement | ADULT, OLDER_ADULT |
Study Design
| Study Type | INTERVENTIONAL |
|---|---|
| Phase | PHASE3 |
Time Information
| Start Date | 2024-04-17 |
|---|---|
| Primary Completion Date | 2027-06-08 |
| Completion Date | 2028-03-06 |